HEPATITIS D
Clinical trials for HEPATITIS D explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS D trials appear
Sign up with your email to follow new studies for HEPATITIS D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise against rare liver infection
Disease control OngoingThis Phase 2 trial tests a new drug called hepalatide (L47) in 90 adults with chronic hepatitis D, a serious liver infection. Participants receive either a low or high dose of hepalatide daily for 48 weeks, or delayed treatment. The main goal is to see if the drug can lower the v…
Matched conditions: HEPATITIS D
Phase: PHASE2 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Tiny study hopes antiviral drug eases dangerous liver pressure
Knowledge-focused OngoingThis observational study follows 11 patients with chronic hepatitis B and delta coinfection and liver cirrhosis who are already receiving the antiviral drug Bulevirtide. Researchers want to see if suppressing the virus reduces portal hypertension—a dangerous buildup of pressure i…
Matched conditions: HEPATITIS D
Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:20 UTC